The new long-acting insulin glargine U300 achieves an early steady state with low risk of accumulation

Diabetes Metab. 2016 Apr;42(2):77-9. doi: 10.1016/j.diabet.2015.11.005. Epub 2015 Dec 10.
No abstract available

Keywords: Accumulation risk; New long-acting insulins; Pharmacodynamics.

MeSH terms

  • Diabetes Mellitus* / drug therapy
  • Diabetes Mellitus* / physiopathology
  • Humans
  • Hypoglycemic Agents* / administration & dosage
  • Hypoglycemic Agents* / pharmacokinetics
  • Hypoglycemic Agents* / therapeutic use
  • Insulin Glargine* / administration & dosage
  • Insulin Glargine* / pharmacokinetics
  • Insulin Glargine* / therapeutic use

Substances

  • Hypoglycemic Agents
  • Insulin Glargine